Companies
Increased demand boosts revenues at Hvivo as it eyes acquisitions
Earnings rose 44 per cent, ahead of analyst expectations
Hvivo, the Irish pharmaceutical services company founded by businessman Cathal Friel, saw record revenue and earnings in 2023 and is eyeing up bolt-on acquisitions.
Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 44 per cent to £13 million (€15.15 million) in the year, ahead of analyst expectations. As previously disclosed, revenue at the firm was up 16 per cent to £56 million.
Yamin Khan, chief executive of Hvivo, said that 2023 marked “yet another ...
